166 related articles for article (PubMed ID: 2120019)
1. Duodenal pH in cystic fibrosis and its relationship to fat malabsorption.
Robinson PJ; Smith AL; Sly PD
Dig Dis Sci; 1990 Oct; 35(10):1299-304. PubMed ID: 2120019
[TBL] [Abstract][Full Text] [Related]
2. Effect of misoprostol on fat malabsorption in cystic fibrosis.
Robinson PJ; Sly PD; Smith AL
Arch Dis Child; 1988 Sep; 63(9):1081-2. PubMed ID: 3140739
[TBL] [Abstract][Full Text] [Related]
3. Twenty-four hour ambulatory gastric and duodenal pH profiles in cystic fibrosis: effect of duodenal hyperacidity on pancreatic enzyme function and fat absorption.
Barraclough M; Taylor CJ
J Pediatr Gastroenterol Nutr; 1996 Jul; 23(1):45-50. PubMed ID: 8811523
[TBL] [Abstract][Full Text] [Related]
4. Placebo-controlled trial of misoprostol in cystic fibrosis.
Robinson P; Sly PD
J Pediatr Gastroenterol Nutr; 1990 Jul; 11(1):37-40. PubMed ID: 2117650
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the 13C-triolein breath test for fat malabsorption in adult patients with cystic fibrosis.
Ritz MA; Fraser RJ; Di Matteo AC; Greville H; Butler R; Cmielewski P; Davidson G
J Gastroenterol Hepatol; 2004 Apr; 19(4):448-53. PubMed ID: 15012784
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects.
Youngberg CA; Berardi RR; Howatt WF; Hyneck ML; Amidon GL; Meyer JH; Dressman JB
Dig Dis Sci; 1987 May; 32(5):472-80. PubMed ID: 3646103
[TBL] [Abstract][Full Text] [Related]
7. Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice.
Wouthuyzen-Bakker M; Bodewes FA; Verkade HJ
J Cyst Fibros; 2011 May; 10(3):150-8. PubMed ID: 21459688
[TBL] [Abstract][Full Text] [Related]
8. Fecal elastase: pancreatic status verification and influence on nutritional status in children with cystic fibrosis.
Cohen JR; Schall JI; Ittenbach RF; Zemel BS; Stallings VA
J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):438-44. PubMed ID: 15795591
[TBL] [Abstract][Full Text] [Related]
9. Association between faecal pH and fat absorption in children with cystic fibrosis on a controlled diet and enzyme supplements dose.
Calvo-Lerma J; Roca M; Boon M; Colombo C; de Koning B; Fornés-Ferrer V; Masip E; Garriga M; Bulfamante A; Asensio-Grau A; Andrés A; de Boeck K; Hulst J; Ribes-Koninckx C
Pediatr Res; 2021 Jan; 89(1):205-210. PubMed ID: 32247283
[TBL] [Abstract][Full Text] [Related]
10. The use of a synthetic prostaglandin E1 analogue (misoprostol) as an adjunct to pancreatic enzyme replacement in cystic fibrosis.
Cleghorn GJ; Shepherd RW; Holt TL
Scand J Gastroenterol Suppl; 1988; 143():142-7. PubMed ID: 3133753
[TBL] [Abstract][Full Text] [Related]
11. Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy.
Li L; Somerset S
Dig Liver Dis; 2014 Oct; 46(10):865-74. PubMed ID: 25053610
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study.
Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C
Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972
[TBL] [Abstract][Full Text] [Related]
13. Fat malabsorption in cystic fibrosis patients.
Murphy J; Laiho K; Wootton S
Am J Clin Nutr; 1999 Nov; 70(5):943-6. PubMed ID: 10539762
[No Abstract] [Full Text] [Related]
14. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis.
Kalnins D; Ellis L; Corey M; Pencharz PB; Stewart C; Tullis E; Durie PR
J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):256-61. PubMed ID: 16540792
[TBL] [Abstract][Full Text] [Related]
15. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
Dutta SK; Hubbard VS; Appler M
Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
[TBL] [Abstract][Full Text] [Related]
16. Fat malabsorption in cystic fibrosis: comparison of quantitative fat assay and a novel assay using fecal lauric/behenic acid.
Dorsey J; Buckley D; Summer S; Jandacek RJ; Rider T; Tso P; Narkewicz MR; Heubi JE
J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):441-6. PubMed ID: 20179641
[TBL] [Abstract][Full Text] [Related]
17. EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency.
Wooldridge JL; Heubi JE; Amaro-Galvez R; Boas SR; Blake KV; Nasr SZ; Chatfield B; McColley SA; Woo MS; Hardy KA; Kravitz RM; Straforini C; Anelli M; Lee C
J Cyst Fibros; 2009 Dec; 8(6):405-17. PubMed ID: 19683970
[TBL] [Abstract][Full Text] [Related]
18. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
19. Failure of taurine to improve fat absorption in cystic fibrosis.
Thompson GN
J Inherit Metab Dis; 1988; 11 Suppl 2():158-60. PubMed ID: 3141698
[No Abstract] [Full Text] [Related]
20. Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis.
Mischler EH; Parrell S; Farrell PM; Odell GB
Am J Dis Child; 1982 Dec; 136(12):1060-3. PubMed ID: 7148760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
